Since the adoption of the Millennium Development Goals in 2000. Significant progress has been made in several areas, including in the area of ​​maternal and child health, as well as in the fight against HIV / AIDS, malaria and other diseases. Since 1990, maternal mortality has declined by almost 50 percent; since 2000, measles vaccination has prevented about 15.6 million deaths from the disease. In addition, by the end of 2014, 13.6 million people had access to antiretroviral therapy. In 2015, the global mortality rate among children under the age of 5 years was 43 deaths per 1000 live births, that is, over the period since 2000, this rate decreased by 44 percent.

However, much remains to be done. Real progress means achieving universal health coverage, access to essential medicines and vaccines, ensuring women's full access to reproductive health services, and completely eliminating preventable child mortality.

The protection of health and the creation of conditions for a healthy lifestyle of the population of the Republic of Uzbekistan is one of the important tasks facing the Government of the country. Proof of this is the relatively good development indicators in the health sector, especially when compared with countries with similar levels of development. So, as a result of the consistent implementation of the concept “Healthy mother is a healthy child” for the period 2011-2015. maternal mortality decreased from 23.1 cases to 19 (per 100 thousand), mortality of children under the age of 5 years from 14.8 to 13.9 per 1000 live births, and infant mortality from 11 to 10.7.

In addition, according to statistics from the World Health Organization, in 2016, life expectancy at birth is 71.3 years, an increase of 4.9 years compared to 1990. The observed progress is partly due to the fact that public spending on health care remains quite high (5.8% of GDP) and is equal to the level of expenditures typical of high-income countries.

At the same time, a number of problems remain unresolved. The burden of disease in Uzbekistan and other Central Asian countries lies with noncommunicable diseases (NCDs), which leads to high costs for treatment, disability and loss of productivity and economic losses. The primary health care system is not well adapted to meet the health needs in general, and in particular the NIB. Although the proportion of deaths due to tuberculosis (TB) and HIV / AIDS has been decreasing gradually since 2000, the prevalence of drug-resistant tuberculosis is growing rapidly and is a serious problem.

National Tasks

3.1-By 2030, reduce by one third the maternal mortality ratio.

3.2-By 2030, reduce by half the mortality of newborns and children under 5 years of age.

3.3-By 2030, reduce the incidence of tuberculosis and HIV, and hepatitis, water-borne diseases and other communicable diseases.

3.4-By 2030, reduce by 30 per cent premature mortality among the population from cardiovascular, oncological diseases, diabetes mellitus and chronic respiratory diseases.

3.5-Strengthen the prevention and treatment of substance abuse, including narcotic drug and alcohol abuse (reducing harmful alcohol consumption by 10 per cent).

3.6-By 2025, halve the number of road traffic accidents, including accidents due to traffic rules violations by pedestrians.

3.7-By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning and raising the marriageable age for girls under 18, and the integration of reproductive health into national strategies and programmes.

3.8-Achieve universal health coverage, including financial risk protection due to high health-care services, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.

3.9-Reduce the number of deaths and illnesses from water and air pollution, hazardous chemicals, including chemical production and disposal sites.

3a-Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control (international convention adopted in May 2003), as appropriate.

National indicators

  2014 2015 2016 2017 2018
Indicator 3.1.1 Maternal mortality rate per 100,000 live births.  19,1 18,9 17,4 21,0 20,2
Republic of Karakalpakstan 22,0 29,0 25,4 13,2 27,4
areas:          
Andijan 17,7 12,9 10,2 11,9 13,8
Bukhara 10,4 7,6 7,8 8,1 19,8
Jizzakh 16,7 25,1 28,5 42,0 26,6
Kashkadarya 15,9 15,3 10,3 26,1 17,1
Navoi 19,9 24,7 24,0 29,2 27,8
Namangan 11,2 8,1 9,7 21,2 12,0
Samarkand 19,4 21,4 18,1 22,2 19,2
Surkhandarya 19,8 18,6 22,4 20,0 27,8
Syrdarya 17,2 5,6 11,3 17,0 27,2
Tashkent 27,7 44,3 35,0 32,9 27,0
Ferghana 18,3 12,6 14,0 21,2 13,5
Khorezm 27,3 15,2 17,9 10,6 15,0
Tashkent city 26,1 25,7 18,2 18,5 28,5
Indicator 3.1.2 Proportion of births attended by skilled health personnel.  100,0 100,0 100,0 100,0 100,0
Indicator 3.2.1 Mortality rate under the age of 5.  13,9 15,1 14,1 15,4 13,1
Republic of Karakalpakstan 16,1 15,7 17,1 20,9 17,3
areas:          
Andijan 15,0 17,6 17,5 19,9 17,4
Bukhara 13,3 13,3 12,4 12,6 9,6
Jizzakh 13,3 13,5 14,2 17,7 13,8
Kashkadarya 11,3 12,5 11,2 13,2 12,9
Navoi 12,0 12,4 11,8 12,5 8,9
Namangan 14,5 16,0 13,7 18,6 15,4
Samarkand 11,3 13,8 10,7 10,3 10,1
Surkhandarya 15,6 15,3 14,8 15,3 14,0
Syrdarya 13,8 16,1 17,8 17,2 15,7
Tashkent 13,5 14,3 14,5 14,3 12,0
Ferghana 12,4 13,1 10,9 10,8 9,2
Khorezm 17,2 17,7 18,1 20,2 15,3
Tashkent city 19,2 22,0 20,1 19,7 14,5
Indicator 3.2.2 Neonatal mortality rate.  7,1 7,9 7,1 7,8 6,9
Republic of Karakalpakstan 8,4 8,7 10,3 12,6 11,1
areas:          
Andijan 8,8 9,8 10,2 11,8 11,4
Bukhara 6,0 6,3 5,6 6,2 4,3
Jizzakh 7,0 6,7 7,7 9,9 6,5
Kashkadarya 5,1 5,8 4,9 5,5 6,2
Navoi 5,9 6,6 6,2 6,8 4,9
Namangan 7,1 8,0 5,5 9,0 8,0
Samarkand 6,7 8,2 5,9 5,0 4,8
Surkhandarya 6,3 6,5 4,9 5,4 6,2
Syrdarya 6,6 8,3 10,7 8,5 8,6
Tashkent 5,6 6,5 6,5 6,2 5,9
Ferghana 5,6 5,4 4,0 4,1 3,6
Khorezm 10,0 11,4 11,5 12,4 9,7
Tashkent city 12,2 15,1 13,4 13,5 9,7
Indicator 3.3.1 Number of new HIV infections per 1000 uninfected people, disaggregated by sex and age.           
a) total 0,138 0,133 0,125 0,131 0,132
b) men 0,152 0,147 0,138 0,149 0,144
c) women 0,123 0,119 0,112 0,113 0,120
d) 0-17 years old 0,067 0,063 0,055 0,051 0,051
e) 18 years and older 0,174 0,169 0,161 0,171 0,172
Indicator 3.3.2.1 Tuberculosis incidence per 100,000 people.           
a) total 47,8 46,9 45,3 44,9 43,0
b) men   53,6 50,3 50,2 46,4
c) women   40,1 40,3 39,6 39,5
d) 0-14 years old 21,3 20,1 22,1 21,0 21,0
e) 15-17 years old 23,8 22,0 23,4 23,2 22,4
f) 18 and older 61,1 60,1 56,9 56,7 53,9
Indicator 3.3.3 Malaria incidence per 1000 population.  0,0 0,0 0,0 0,0 0,0
Indicator 3.3.4.1 Hepatitis B incidence per 100,000 people  1,1 1,1 0,8 0,8 0,6
Indicator 3.3.4.2 Hepatitis C incidence per 100,000 people.  0,3 0,3 0,2 0,2 0,2
Indicator 3.4.1 Age-standardized mortality rate among people aged 30-69 attributed to cardiovascular disease, malignant neoplasms, diabetes mellitus and chronic respiratory disease.  288,6 279,7 281,2 279,3 264,9
a) circulatory system diseases (I00-I99) 213,1 202,1 203,9 201,1 191,2
b) malignant neoplasms (C00-C97) 48,1 49,8 50,6 51,3 48,2
c) type 2 diabetes mellitus (E10-E14) 21,5 22,3 21,4 21,4 19,7
d) chronic respiratory disease (J30-J99) 5,9 5,6 5,2 5,6 5,8
Indicator 3.4.2 Suicide mortality by gender and age.  6,8 7,6 7,7 7,5 6,9
Indicator 3.5.1 The incidence of narcological disease per 100,000 people:           
a) addiction 3,8 3,0 3,0 2,5 2,6
b) alcoholism 17,1 16,3 18,0 21,0 19,3
c) substance abuse 0,1 0,1 0,1 0,1 0,1
Indicator 3.5.2 Alcohol consumption per capita aged 15 years and older in liters of pure alcohol within a calendar year.  7,0 7,0 7,0 6,3 6,4
Republic of Karakalpakstan         7,6
areas:          
Andijan - - - - 4,4
Bukhara - - - - 12,9
Jizzakh - - - - 9,0
Kashkadarya - - - - 4,0
Navoi - - - - 6,4
Namangan - - - - 7,5
Samarkand - - - - 4,5
Surkhandarya - - - - 3,8
Syrdarya - - - - 12,5
Tashkent - - - - 28,5
Ferghana - - - - 4,2
Khorezm - - - - 6,6
Tashkent city - - - - 20,3
Indicator 3.6.1 Road traffic deaths.  7,8 8,1 7,9 7,6 6,9
Indicator 3.7.1 Coverage of women of reproductive age (15-49 years old) with modern contraceptives,% of their number 47,7 49,5 52,9 52,3 51,0
Indicator 3.7.2 Adolescent birth rate (aged 15 to 19 years) per 1000 women in that age group 24,2 23,8 21,0 19,0 21,9
Indicator 3.8.2. Percentage of the population with a high proportion of family expenses for medical care in total  household expenditure          
a) more than 10% of expenses 8,7 10,9 10,9 12,5 13,8
b) more than 25% of expenses 2,3 2,2 2,1 2,5 3,0
Indicator 3.9.1 Mortality due tohazardous chemicals per 100,000 people 0,195 0,227 0,000 0,207 0,200
Indicator 3.9.2 Mortality due to unsafe water, unsafe sanitation and lack of hygiene (exposure to unsafe Water, Sanitation and Hygiene for All (WASH) services) 0,042 0,042 0,028 0,043 0,018
Indicator 3.9.3 Mortality due to unintentional poisoning 1,2 1,1 1,0 1,3 1,1
Indicator 3.a.1 Age-standardized prevalence of tobacco use among persons aged 15 years and older, by gender - - - - 11,9
Indicator 3.b.1 Percentage of children covered by the vaccines included in the national immunization schedule (diphtheria, pertussis, tetanus, measles, rubella, mumps, meningococcal disease, tuberculosis, rotavirus infection, hepatitis B, polio, pneumococcal disease, papilloma virus) 99,4 99,8 99,8 99,7 99,8
Indicator 3.c.1 Number of health workers per capita and their distribution by region          
a) number of doctors of all specialties per 10,000 population 26,4 26,4 26,2 26,1 27,0
b) number of secondary medical personnel per 10,000 population 107,2 106,5 106,3 106,6 107,3